Now, weight loss drug semaglutide can lower risk of kidney disease by 24 per cent | Health and Wellness News
The popular diabetes and weight-loss drug semaglutide — sold under the brand names Ozempic and Wegovy — has now been proven to reduce the risk of kidney disease and its complications among people with diabetes. A recent study has found that it could reduce the risk of major kidney events, onset of dialysis, or transplantation …